BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for North American Extreme

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $4354.20.64 only $1741.68

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.58
-0.02%
US Tech 100
20,355.20
0.45%
S&P 500
6,021.63
0.57%
US Dollar vs CAD
1.40695
0.11%
Bitcoin
92,536.49
0.61%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vallon Pharmaceuticals Inc (VLON)

  7. Vallon Pharmaceuticals Inc (VLON) Financials

Vallon Pharmaceuticals Inc

Vallon Pharmaceuticals Inc (VLON)

NASDAQ
0.40
0.00
(0.00%)
Closed November 26 3:00PM
Delayed by 15 minutes
0.00
0.00
(0.00%)
After Hours: -
Delayed by 15 minutes

Vallon Pharmaceuticals Inc Financial Summary

The current VLON market cap is 1.3M. The company's latest EPS is USD -4.0163 and P/E is -0.10.

Income Statement

Annual Quarterly
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000
Operating Income -4.57M-2.44M-2.03M-1.9M-2.26M
Net Income -6.5M-2.14M-2M-1.89M-2.25M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 0100k000
Operating Income -3.15M-4.79M-9.26M-6.93M-11.39M
Net Income -3.46M-4.82M-9.3M-7.02M-13.04M

Balance Sheet

Annual Quarterly
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 5.64M4.4M2.96M4.59M7.03M
Total Liabilities 1.6M2.18M2.7M1.79M2.31M
Total Equity 4.04M2.23M259k2.8M4.72M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Assets 4.28M955k8.34M4.15M2.96M
Total Liabilities 1.06M2.41M2.52M1.81M2.7M
Total Equity 3.21M-1.45M5.82M2.34M259k

Cash Flow

Annual Quarterly
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -2.12M-3.43M-8.99M-2.2M-4.34M
Investing -8k-8k-8k N/A N/A
Financing 6.92M6.92M10.8M4.49M8.89M
Year End December 30 2023 20192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Operating -2.88M-3.71M-8.31M-7.14M-8.99M
Investing N/A -2k-3.84M3.78M-8k
Financing 6.09M-4k15.75M3.43M10.8M

Stats and Ratios

Market Cap 1.3M
Price to Earnings Ratio -0.10
Price to Sales Ratio 0
Price to Cash Ratio 0.72
Price to Book Ratio 5.01
Dividend Yield -

Share Statistics

Shares Outstanding 3.25M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 0.01 (2.38%)

Company Info

Company Name Vallon Pharmaceuticals Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://vallonpharmaceutical
Industry pharmaceutical preparations (2834)

Your Recent History

NASDAQ
VLON
Vallon Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for Canada: TSX and TSXV Level 1

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1305.00 only $522.00